CRC has an immunosuppressive TME which stops the development of a highly effective response to ICB therapies. There is thus an urgent must determine the ways reprogram this suppressive TME in order to greatly enhance immunotherapy efficacy. In The existing analyze, we applied CRISPR KO screens to find genes that https://as184285655432.amoblog.com/this-article-is-under-review-50400213